Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
Review
. 2022 Mar 14:2022:3861092.
doi: 10.1155/2022/3861092. eCollection 2022.

Prognostic and Diagnostic Value of Endocan in Kidney Diseases

Affiliations
Review

Prognostic and Diagnostic Value of Endocan in Kidney Diseases

Elisabeth Samouilidou et al. Int J Nephrol. .

Abstract

Endocan, previously called endothelial cell-specific molecule-1, is a soluble proteoglycan that is predominantly expressed in vascular endothelial cells of the lungs and kidneys. It is upregulated by proinflammatory cytokines and plays a critical role in inflammatory, proliferative, and neovascularization processes. The utility of endocan as a biomarker in a wide spectrum of diseases is being increasingly acknowledged. In this review, we summarize the current evidence concerning the role of endocan in kidney diseases, with emphasis on its prognostic and diagnostic value. It seems that the determination of plasma endocan levels may provide useful prognostic information in many types of renal failure such as chronic kidney disease, IgA nephropathy, and diabetic nephropathy. Endocan could additionally improve the early diagnostic evaluation of acute kidney disease, chronic renal allograft injury, and acute rejection after kidney transplantation, thus contributing to endothelial cell injury monitoring in a timely manner.

PubMed Disclaimer

Conflict of interest statement

The authors have no conflicts of interest to declare.

Figures

Figure 1
Figure 1
The prognostic and diagnostic value of endocan in kidney diseases.

Similar articles

Cited by

References

    1. Lassalle P., Molet S., Janin A., et al. ESM-1 is a novel human endothelial cell-specific molecule expressed in lung and regulated by cytokines. Journal of Biological Chemistry . 1996;271(34):20458–20464. doi: 10.1074/jbc.271.34.20458. - DOI - PubMed
    1. Béchard D., Gentina T., Delehedde M., et al. Endocan is a novel chondroitin sulfate/dermatan sulfate proteoglycan that promotes hepatocyte growth factor/scatter factor mitogenic activity. Journal of Biological Chemistry . 2001;276:48341–48349. doi: 10.1074/jbc.M108395200. - DOI - PubMed
    1. Bechard D., Meignin V., Scherpereel A., et al. Characterization of the secreted form of endothelial-cell-specific molecule 1 by specific monoclonal antibodies. Journal of Vascular Research . 2000;37:417–425. doi: 10.1159/000025758. - DOI - PubMed
    1. Mikkelsen M. E., Shah C. V., Scherpereel A., et al. Lower serum endocan levels are associated with the development of acute injury after major trauma. Journal of Critical Care . 2012;27:522–532. doi: 10.1016/j.jcrc.2011.07.077. - DOI - PMC - PubMed
    1. Tang l, Zhao Y., Wang D., et al. Endocan levels in peripheral blood predict outcomes of acute respiratory distress syndrome. Mediators of Inflammation . 2014;2014 doi: 10.1155/2014/625180.625180 - DOI - PMC - PubMed

LinkOut - more resources